Overview

A Long-term Safety Study of Infliximab (Remicade)

Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
This is a study evaluating the long-term safety of infliximab (Remicade)
Details
Lead Sponsor:
Centocor, Inc.
Collaborator:
Centocor BV
Treatments:
Infliximab